跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用醋酸地加瑞克 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Degarelix Acetate for Injection
Approved
化学药品
Degarelix Acetate for Injection
Ferring Pharmaceuticals A/S
🇨🇳 National Medical Products Administration
Approval Date
Mar 1, 2024
Approval ID
8bLYDKCUb3D
Company
Ferring Pharmaceuticals A/S
Type
化学药品
Approval Details
Approval Id
8bLYDKCUb3D
Approval Number
国药准字HJ20180053
Generic Name
注射用醋酸地加瑞克
Generic Name En
Degarelix Acetate for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
120mg (按地加瑞克(C₈₂H₁₀₃N₁₈O₁₆Cl)计算)
Reg Date
2024-03-01
Expired Date
2029-02-28
Company Name
Ferring Pharmaceuticals A/S
Production Company Name
Ferring GmbH
Company Detail Path
/organization/ferring-pharmaceuticals-a-s
Production Company Detail Path
/organization/ferring-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 1, 2024
Approval ID
8bLYDKCUb3D
Type
化学药品
Back to NMPA Approvals